Osama Albarbarawi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Osama Albarbarawi has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Daan M. F. van Aalten
Section for Neurobiology and DANDRITE, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark
5 shared publications Alun Barton
Translational Medicine Research Collaboration, TMRC Laboratory, James Arrott Drive, Dundee, DD1 9SY, UK
3 shared publications- Colin Neil Alexander Palmer
University of Dundee
3 shared publications Douglas Miller
Clinical Research, Pfizer Worldwide R&D, Dundee, UK
3 shared publications- Marianne Schimpl
AstraZeneca
3 shared publications R. Avidad
University of Granada
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Indoor Air
- Vol. 2026 (1)
Indoor Air Quality and Exposure Characterization in Operational Waterpipe Cafés: Field Measurements of Particulate and Volatile Pollutants in Al‐Madinah Al‐Munawwarah
Waterpipe cafés represent combustion‐dominated indoor environments where tobacco heating and charcoal burning generate complex mixtures of airborne pollutants. Despite the widespread presence of such venues in Saudi Arabia and globally, quantitative field measurements describing real‐world exposure conditions remain limited, particularly in the Gulf region. This study characterizes indoor air quality in five operational waterpipe cafés in Al‐Madinah Al‐Munawwarah through direct measurements of particulate matter (PM₂.₅ and PM₁₀), total volatile organic compounds (TVOCs), and formaldehyde (HCHO) during peak occupancy periods on weekdays and weekends. Substantial spatial and temporal variability in pollutant concentrations was observed across venues, largely reflecting differences in smoking intensity and ventilation effectiveness. Mean weekday PM₂.₅ and PM₁₀ concentrations reached 285.5 ± 149 μ g/m 3 and 301.6 ± 156 μ g/m 3 , respectively, while weekend TVOC concentrations averaged 0.50 mg/m 3 . In multiple instances, measured particulate and volatile pollutant levels exceeded international health‐based guideline values, indicating elevated exposure potential under high‐use conditions. Formaldehyde concentrations remained below short‐term reference thresholds. The findings identify waterpipe cafés as significant indoor sources of fine particulate matter and volatile pollutants. This study provides region‐specific evidence supporting the need for stricter indoor air quality regulations in waterpipe café environments. The results contribute to advancing national priorities in public health protection, environmental sustainability, and urban environmental management within Saudi Arabia.
- 1 January 2026
- Published by Wiley in Indoor Air
- Vol. 2026 (1)
Open AccessIndoor Air Quality and Exposure Characterization in Operational Waterpipe Cafés: Field Measurements of Particulate and Volatile Pollutants in Al‐Madinah Al‐Munawwarah
Waterpipe cafés represent combustion‐dominated indoor environments where tobacco heating and charcoal burning generate complex mixtures of airborne pollutants. Despite the widespread presence of such venues in Saudi Arabia and globally, quantitative field measurements describing real‐world exposure conditions remain limited, particularly in the Gulf region. This study characterizes indoor air quality in five operational waterpipe cafés in Al‐Madinah Al‐Munawwarah through direct measurements of particulate matter (PM₂.₅ and PM₁₀), total volatile organic compounds (TVOCs), and formaldehyde (HCHO) during peak occupancy periods on weekdays and weekends. Substantial spatial and temporal variability in pollutant concentrations was observed across venues, largely reflecting differences in smoking intensity and ventilation effectiveness. Mean weekday PM₂.₅ and PM₁₀ concentrations reached 285.5 ± 149 μ g/m 3 and 301.6 ± 156 μ g/m 3 , respectively, while weekend TVOC concentrations averaged 0.50 mg/m 3 . In multiple instances, measured particulate and volatile pollutant levels exceeded international health‐based guideline values, indicating elevated exposure potential under high‐use conditions. Formaldehyde concentrations remained below short‐term reference thresholds. The findings identify waterpipe cafés as significant indoor sources of fine particulate matter and volatile pollutants. This study provides region‐specific evidence supporting the need for stricter indoor air quality regulations in waterpipe café environments. The results contribute to advancing national priorities in public health protection, environmental sustainability, and urban environmental management within Saudi Arabia.
- 29 December 2024
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1327
Porphyrin Schiff bases as potential Alzheimer's disease drug candidates: Synthesis, in silico and DFT studies
- 29 December 2024
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1327
Porphyrin Schiff bases as potential Alzheimer's disease drug candidates: Synthesis, in silico and DFT studies
- Open Access
- 3 March 2023
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 30 (4) , 564
Author Correction: The active site of O-GlcNAc transferase imposes constraints on substrate sequence
- 3 March 2023
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 30 (4) , 564
Open AccessAuthor Correction: The active site of O-GlcNAc transferase imposes constraints on substrate sequence
- 1 January 2023
- Published by Medwin Publishers in Medicinal and Analytical Chemistry International Journal
- Vol. 7 (1)
Aspect of COVID-19 Pandemic: Case for Mass Spectrometry
Fast spread of COVID-19 worldwide causing unprecedented number of coronavirus infections, Scientist community are in race to control the disease by the development of both novel effective diagnostics strategies and effective therapies. Ultimately an efficient vaccine. Research efforts has focused on recognition of the pathogen entry mechanisms to the host's cells, simultaneously characterize the host’s cellular defence mechanisms in response to the pathogen attack. Early genome sequencing enlighten us on the origin of the virus responsible for the severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) pandemic. PCR tests first implemented to recognize the presence of viral RNA. PCR tests for SARS-CoV-2 has no gold standard reference, which limits the accuracy of results and increases the percentages of false positives, besides PCR test are unable to predict disease status (progression). Alternative techniques where tested and evaluated, such as immunological based tests. Mass spectrometric methods. Which was suggested as a complementary method to the structural information gathered by molecular level test? Here, we highlight on the contributions of mass spectrometry to several areas of SARS-CoV-2 infectious disease research understanding the host’s cell proteome changes including diagnostics techniques, vaccines and therapies.
- 1 January 2023
- Published by Medwin Publishers in Medicinal and Analytical Chemistry International Journal
- Vol. 7 (1)
Aspect of COVID-19 Pandemic: Case for Mass Spectrometry
Fast spread of COVID-19 worldwide causing unprecedented number of coronavirus infections, Scientist community are in race to control the disease by the development of both novel effective diagnostics strategies and effective therapies. Ultimately an efficient vaccine. Research efforts has focused on recognition of the pathogen entry mechanisms to the host's cells, simultaneously characterize the host’s cellular defence mechanisms in response to the pathogen attack. Early genome sequencing enlighten us on the origin of the virus responsible for the severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) pandemic. PCR tests first implemented to recognize the presence of viral RNA. PCR tests for SARS-CoV-2 has no gold standard reference, which limits the accuracy of results and increases the percentages of false positives, besides PCR test are unable to predict disease status (progression). Alternative techniques where tested and evaluated, such as immunological based tests. Mass spectrometric methods. Which was suggested as a complementary method to the structural information gathered by molecular level test? Here, we highlight on the contributions of mass spectrometry to several areas of SARS-CoV-2 infectious disease research understanding the host’s cell proteome changes including diagnostics techniques, vaccines and therapies.
- 3 August 2015
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 22 (9) , 744-750
The active site of O-GlcNAc transferase imposes constraints on substrate sequence
O-GlcNAcylation is a post-translational modification catalyzed by O-GlcNAc transferase. Here, a high-throughput activity assay combined with mass spectrometric and crystallographic analyses sheds light on the substrate recognition and specificity of O-GlcNAc transferase. O-GlcNAc transferase (OGT) glycosylates a diverse range of intracellular proteins with O-linked N-acetylglucosamine (O-GlcNAc), an essential and dynamic post-translational modification in metazoans. Although this enzyme modifies hundreds of proteins with O-GlcNAc, it is not understood how OGT achieves substrate specificity. In this study, we describe the application of a high-throughput OGT assay to a library of peptides. We mapped sites of O-GlcNAc modification by electron transfer dissociation MS and found that they correlate with previously detected O-GlcNAc sites. Crystal structures of four acceptor peptides in complex with Homo sapiens OGT suggest that a combination of size and conformational restriction defines sequence specificity in the −3 to +2 subsites. This work reveals that although the N-terminal TPR repeats of OGT may have roles in substrate recognition, the sequence restriction imposed by the peptide-binding site makes a substantial contribution to O-GlcNAc site specificity.
- 3 August 2015
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 22 (9) , 744-750
The active site of O-GlcNAc transferase imposes constraints on substrate sequence
O-GlcNAcylation is a post-translational modification catalyzed by O-GlcNAc transferase. Here, a high-throughput activity assay combined with mass spectrometric and crystallographic analyses sheds light on the substrate recognition and specificity of O-GlcNAc transferase. O-GlcNAc transferase (OGT) glycosylates a diverse range of intracellular proteins with O-linked N-acetylglucosamine (O-GlcNAc), an essential and dynamic post-translational modification in metazoans. Although this enzyme modifies hundreds of proteins with O-GlcNAc, it is not understood how OGT achieves substrate specificity. In this study, we describe the application of a high-throughput OGT assay to a library of peptides. We mapped sites of O-GlcNAc modification by electron transfer dissociation MS and found that they correlate with previously detected O-GlcNAc sites. Crystal structures of four acceptor peptides in complex with Homo sapiens OGT suggest that a combination of size and conformational restriction defines sequence specificity in the −3 to +2 subsites. This work reveals that although the N-terminal TPR repeats of OGT may have roles in substrate recognition, the sequence restriction imposed by the peptide-binding site makes a substantial contribution to O-GlcNAc site specificity.
- Open Access
- 4 September 2013
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 33 (5) , e00063-699
Genetic and structural validation of Aspergillus fumigatus N-acetylphosphoglucosamine mutase as an antifungal target
Aspergillus fumigatus is the causative agent of IA (invasive aspergillosis) in immunocompromised patients. It possesses a cell wall composed of chitin, glucan and galactomannan, polymeric carbohydrates synthesized by processive glycosyltransferases from intracellular sugar nucleotide donors. Here we demonstrate that A. fumigatus possesses an active AfAGM1 (A. fumigatus N-acetylphosphoglucosamine mutase), a key enzyme in the biosynthesis of UDP (uridine diphosphate)–GlcNAc (N-acetylglucosamine), the nucleotide sugar donor for chitin synthesis. A conditional agm1 mutant revealed the gene to be essential. Reduced expression of agm1 resulted in retarded cell growth and altered cell wall ultrastructure and composition. The crystal structure of AfAGM1 revealed an amino acid change in the active site compared with the human enzyme, which could be exploitable in the design of selective inhibitors. AfAGM1 inhibitors were discovered by high-throughput screening, inhibiting the enzyme with IC50s in the low μM range. Together, these data provide a platform for the future development of AfAGM1 inhibitors with antifungal activity.
- 4 September 2013
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 33 (5) , e00063-699
Open AccessGenetic and structural validation of Aspergillus fumigatus N-acetylphosphoglucosamine mutase as an antifungal target
Aspergillus fumigatus is the causative agent of IA (invasive aspergillosis) in immunocompromised patients. It possesses a cell wall composed of chitin, glucan and galactomannan, polymeric carbohydrates synthesized by processive glycosyltransferases from intracellular sugar nucleotide donors. Here we demonstrate that A. fumigatus possesses an active AfAGM1 (A. fumigatus N-acetylphosphoglucosamine mutase), a key enzyme in the biosynthesis of UDP (uridine diphosphate)–GlcNAc (N-acetylglucosamine), the nucleotide sugar donor for chitin synthesis. A conditional agm1 mutant revealed the gene to be essential. Reduced expression of agm1 resulted in retarded cell growth and altered cell wall ultrastructure and composition. The crystal structure of AfAGM1 revealed an amino acid change in the active site compared with the human enzyme, which could be exploitable in the design of selective inhibitors. AfAGM1 inhibitors were discovered by high-throughput screening, inhibiting the enzyme with IC50s in the low μM range. Together, these data provide a platform for the future development of AfAGM1 inhibitors with antifungal activity.
- 13 August 2013
- Published by Taylor & Francis in Bioanalysis
- Vol. 5 (16) , 1991-2001
Characterization and Validation of an Isotope-Dilution LC–MS/MS Method for Quantification of Total Desmosine and Isodesmosine in Plasma and Serum
Desmosine/isodesmosine (DES/IDS) is a promising biomarker for estimating activity of elastin degradation. RESULTS/METHODOLOGY: A stable isotope dilution LC-MS/MS method for measuring serum/plasma DES/IDS was developed and validated. The reportable range of this assay was 0.1-160 ng/ml. Serum/plasma DES/IDS level was stable at room temperature or 4°C for 20 h, and for three freeze-thaw cycles. Interferences from endogenous compounds and ion suppression/enhancing effect were also evaluated. Our results suggest the absolute necessity of using an IS in the measurement. We found that serum/plasma DES/IDS levels from patients with chronic obstructive pulmonary disease and cystic fibrosis were significantly higher compared with healthy smokers. These results demonstrate that the LC-MS/MS method provides sensitive, reproducible and accurate quantification of total serum/plasma DES/IDS.
- 13 August 2013
- Published by Taylor & Francis in Bioanalysis
- Vol. 5 (16) , 1991-2001
Characterization and Validation of an Isotope-Dilution LC–MS/MS Method for Quantification of Total Desmosine and Isodesmosine in Plasma and Serum
Desmosine/isodesmosine (DES/IDS) is a promising biomarker for estimating activity of elastin degradation. RESULTS/METHODOLOGY: A stable isotope dilution LC-MS/MS method for measuring serum/plasma DES/IDS was developed and validated. The reportable range of this assay was 0.1-160 ng/ml. Serum/plasma DES/IDS level was stable at room temperature or 4°C for 20 h, and for three freeze-thaw cycles. Interferences from endogenous compounds and ion suppression/enhancing effect were also evaluated. Our results suggest the absolute necessity of using an IS in the measurement. We found that serum/plasma DES/IDS levels from patients with chronic obstructive pulmonary disease and cystic fibrosis were significantly higher compared with healthy smokers. These results demonstrate that the LC-MS/MS method provides sensitive, reproducible and accurate quantification of total serum/plasma DES/IDS.
- Open Access
- 28 October 2012
- Published by Springer Nature in Nature Chemical Biology
- Vol. 8 (12) , 969-974
O-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysis
OGT modifies numerous proteins with O-GlcNAc, but the mechanism for this reaction has been difficult to define. Ternary crystal structures and activity assays with substrate analogs now provide evidence that the α-phosphate of the donor substrate is the catalytic base. Protein O-GlcNAcylation is an essential post-translational modification on hundreds of intracellular proteins in metazoa, catalyzed by O-linked β-N-acetylglucosamine (O-GlcNAc) transferase (OGT) using unknown mechanisms of transfer and substrate recognition. Through crystallographic snapshots and mechanism-inspired chemical probes, we define how human OGT recognizes the sugar donor and acceptor peptide and uses a new catalytic mechanism of glycosyl transfer, involving the sugar donor α-phosphate as the catalytic base as well as an essential lysine. This mechanism seems to be a unique evolutionary solution to the spatial constraints imposed by a bulky protein acceptor substrate and explains the unexpected specificity of a recently reported metabolic OGT inhibitor.
- 28 October 2012
- Published by Springer Nature in Nature Chemical Biology
- Vol. 8 (12) , 969-974
Open AccessO-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysis
OGT modifies numerous proteins with O-GlcNAc, but the mechanism for this reaction has been difficult to define. Ternary crystal structures and activity assays with substrate analogs now provide evidence that the α-phosphate of the donor substrate is the catalytic base. Protein O-GlcNAcylation is an essential post-translational modification on hundreds of intracellular proteins in metazoa, catalyzed by O-linked β-N-acetylglucosamine (O-GlcNAc) transferase (OGT) using unknown mechanisms of transfer and substrate recognition. Through crystallographic snapshots and mechanism-inspired chemical probes, we define how human OGT recognizes the sugar donor and acceptor peptide and uses a new catalytic mechanism of glycosyl transfer, involving the sugar donor α-phosphate as the catalytic base as well as an essential lysine. This mechanism seems to be a unique evolutionary solution to the spatial constraints imposed by a bulky protein acceptor substrate and explains the unexpected specificity of a recently reported metabolic OGT inhibitor.
- Open Access
- 3 February 2012
- Published by Springer Nature in The EMBO Journal
- Vol. 31 (6) , 1394-1404
O‐GlcNAcylation of TAB1 modulates TAK1‐mediated cytokine release
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 3 February 2012
- Published by Springer Nature in The EMBO Journal
- Vol. 31 (6) , 1394-1404
Open AccessO‐GlcNAcylation of TAB1 modulates TAK1‐mediated cytokine release
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- Open Access
Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease
Background Although an increased concentration of degraded elastin products in patients with chronic obstructive pulmonary disease (COPD) has been reported for many years, its clinical validity and utility remain uncertain due to technical difficulties, small study groups and the unknown relationship between exacerbation and elastin degradation. The objectives of this study were to determine the validity of urinary and blood total desmosine/isodesmosine in patients with COPD and asthma and to evaluate their relationship to exacerbation status and lung function. Methods Urinary and blood desmosine levels were measured using validated isotopic dilution liquid chromatography–tandem mass spectrometry methods. Results 390 study participants were recruited from the following groups: healthy volunteers, stable asthma, stable and ‘during an exacerbation’ COPD. Compared with healthy non-smokers, we found increased urinary or blood desmosine levels in patients with COPD, but no differences in patients with asthma or healthy smokers. The elevation of urinary desmosine levels was associated with the exacerbation status in patients with COPD. Approximately 40% of patients with stable and ‘during an exacerbation’ COPD showed elevated blood desmosine levels. Blood desmosine levels were strongly associated with age and were negatively correlated with lung diffusing capacity for carbon monoxide. Conclusion The results suggest that urinary desmosine levels are raised by exacerbations of COPD whereas blood desmosine levels are elevated in a subgroup of patients with stable COPD and reduced lung diffusing capacity. The authors speculate that a raised blood desmosine level may identify patients with increased elastin degradation suitable for targeted therapy. Future prospective studies are required to investigate this hypothesis.
Open AccessClinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease
Background Although an increased concentration of degraded elastin products in patients with chronic obstructive pulmonary disease (COPD) has been reported for many years, its clinical validity and utility remain uncertain due to technical difficulties, small study groups and the unknown relationship between exacerbation and elastin degradation. The objectives of this study were to determine the validity of urinary and blood total desmosine/isodesmosine in patients with COPD and asthma and to evaluate their relationship to exacerbation status and lung function. Methods Urinary and blood desmosine levels were measured using validated isotopic dilution liquid chromatography–tandem mass spectrometry methods. Results 390 study participants were recruited from the following groups: healthy volunteers, stable asthma, stable and ‘during an exacerbation’ COPD. Compared with healthy non-smokers, we found increased urinary or blood desmosine levels in patients with COPD, but no differences in patients with asthma or healthy smokers. The elevation of urinary desmosine levels was associated with the exacerbation status in patients with COPD. Approximately 40% of patients with stable and ‘during an exacerbation’ COPD showed elevated blood desmosine levels. Blood desmosine levels were strongly associated with age and were negatively correlated with lung diffusing capacity for carbon monoxide. Conclusion The results suggest that urinary desmosine levels are raised by exacerbations of COPD whereas blood desmosine levels are elevated in a subgroup of patients with stable COPD and reduced lung diffusing capacity. The authors speculate that a raised blood desmosine level may identify patients with increased elastin degradation suitable for targeted therapy. Future prospective studies are required to investigate this hypothesis.